Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. (Q48889959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Bruce J Brew

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Bruce J Brew

series ordinal

2

1 reference

http://europepmc.org/abstract/MED/21416169

16 February 2018

publication date

17 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

Journal of NeuroVirology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

176-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21416169%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13365-011-0021-x

25 January 2020

exact match

0 references

cites work

Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months.

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

HIV and age do not substantially interact in HIV-associated neurocognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Neuropsychological aspects of coinfection with HIV and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

What's wrong with Bonferroni adjustments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Developments in HIV neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

What is cognitive reserve? Theory and research application of the reserve concept

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

21 January 2018

12 December 2020

Factors associated with incident human immunodeficiency virus-dementia

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Infection of stationary human brain aggregates with HIV-1 SF162 and IIIB results in transient neuronal damage and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

HIV infection and dementia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0021-X

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex

21 January 2018

1 reference

12 December 2020

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

12 December 2020

Neurodegeneration and ageing in the HAART era.

1 reference

12 December 2020

Neuropsychological performance of HIV-1 infected men with major depression. HNRC Group. HIV Neurobehavioral Research Center.

1 reference

12 December 2020

Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex

1 reference

12 December 2020

Incident major depression does not affect neuropsychological functioning in HIV-infected men.

1 reference

12 December 2020

New drugs for HIV therapy

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Demographically corrected norms for the California Verbal Learning Test

1 reference

12 December 2020